Table 1.
Patient, disease, and treatment characteristics for 283 patients with skin diseases
| Female | Male | Total | P value | |
|---|---|---|---|---|
|
|
||||
| n (%) | n (%) | n (%) | ||
| Patient characteristics | ||||
| Age, years# | ||||
| 15–24 | 69 (40.4) | 27 (29.7) | 96 (36.6) | P = 0.14 |
| 25–39 | 64 (37.4) | 45 (49.5) | 109 (41.6) | |
| 40–59 | 38 (22.2) | 19 (20.9) | 57 (21.8) | |
| Origin | ||||
| Urban | 165 (92.2) | 93 (89.4) | 258 (91.2) | P = 0.43 |
| Rural | 14 (7.8) | 11 (10.6) | 25 (8.8) | |
| Marital status | ||||
| Single | 78 (43.6) | 36 (34.6) | 114 (40.3) | P < 0.001 |
| Married | 85 (47.5) | 66 (63.5) | 151 (53.4) | |
| Divorced/widow | 16 (8.9) | 2 (1.9) | 18 (6.4) | |
| Education level | ||||
| Less than secondary | 44 (24.6) | 14 (13.5) | 58 (20.5) | P = 0.025 |
| Secondary or more | 135 (75.4) | 90 (86.5) | 225 (79.5) | |
| Monthly income | ||||
| <3000 SR | 15 (8.4) | 6 (5.8) | 21 (7.4) | P = 0.31 |
| 3000–5000 SR | 47 (26.3) | 21 (20.2) | 68 (24.0) | |
| >5000 SR | 117 (65.4) | 77 (74.0) | 194 (68.6) | |
| Disease characteristics | ||||
| Duration of disease | ||||
| <1 week | 3 (1.7) | 2 (1.9) | 5 (1.8) | P = 0.35 |
| 1–4 weeks | 13 (7.3) | 6 (5.8) | 19 (6.7) | |
| 1–6 months | 27 (15.1) | 12 (11.5) | 39 (13.8) | |
| >6 months | 136 (76.0) | 84 (80.8) | 220 (77.7) | |
| Family history of same lesion | ||||
| No | 130 (72.6) | 73 (70.2) | 203 (71.7) | P = 0.66 |
| Yes | 49 (27.4) | 31 (29.8) | 80 (28.3) | |
| Spread of skin lesion | ||||
| Generalized | 77 (43.0) | 47 (45.2) | 124 (43.8) | P = 0.72 |
| Localized | 102 (57.0) | 57 (54.8) | 159 (56.2) | |
| Presence of comorbidity | ||||
| Yes | 58 (32.4) | 31 (29.8) | 89 (31.4) | P = 0.65 |
| No | 121 (67.6) | 73 (70.2) | 194 (68.6) | |
| Treatment characteristics | ||||
| Using steroids | 33 (25.8) | 22 (27.2) | 55 (19.5) | P = 0.58 |
| Using isotretinoin | 25 (19.5) | 10 (12.3) | 35 (12.5) | P = 0.29 |
| Using other medications | 70 (54.7) | 49 (60.5) | 119 (41.9) | |
| Topical* | 74 (46.8) | 54 (50.0) | 128 (64.3) | |
| Tablets* | 54 (34.2) | 30 (27.8) | 84 (42.2) | |
| Psoralen + ultraviolet A* | 14 (8.9) | 11 (10.2) | 25 (12.6) | |
| Injection* | 2 (1.3) | 4 (3.7) | 6 (3.0) | |
| Others (eg, laser, surgery)* | 14 (8.9) | 9 (8.3) | 23 (11.6) | |
Notes: Duration was categorized into “>6 months” and “other” during the statistical analysis.
#
Exact age was unknown for 21 patients.
*
not mutually exclusive.
Abbreviation: SR, Saudi riyals.